Spencer Strider is the latest Atlanta Braves pitcher to see his season thrown into doubt, and the early returns from the MRI results are far from reassuring. According to the Associated Press, the MRI showed inflammation in Strider’s right elbow, but the team won’t determine next steps until renowned orthopedic surgeon Dr. Keith Meister reviews the full imaging. That wait has already set off alarm bells across the league.
The Braves placed Strider on the 15-day injured list after his start against the New York Mets last Friday. He struggled through four innings, allowing four earned runs on five hits while striking out four. It was clear something wasn’t right. The velocity was there — he still hit 99 mph — but command looked off, and his slider lacked its usual bite. Postgame, Strider didn’t offer specifics, simply saying his elbow felt “tight.”
For a team already dealing with key injuries in the rotation — Max Fried and Kyle Wright have both missed time — Strider’s uncertain status is a gut punch. The Braves are trying to hold off a resurgent New York Mets team in the NL East, and losing Strider for anything beyond a minimal IL stint would force the front office to scramble. Atlanta’s depth is thin in the upper minors, which means trade talks could heat up faster than expected.
Fans and analysts online have pointed to the involvement of Dr. Meister as an ominous sign. Meister is one of the most respected elbow specialists in baseball, and pitchers are typically referred to him when Tommy John surgery is a possibility. The team has not confirmed whether surgery is on the table, and they’re careful not to speculate publicly. But the timeline — wait for Meister’s review, then decide — mirrors the path many pitchers have walked before landing on the operating table.
The Braves have managed Strider’s workload since he debuted in 2021, limiting his innings and giving him extra rest when possible. Last season, he led the majors in strikeouts but also ranked near the top in pitch count per start. The hope is that rest and anti-inflammatory treatment will be enough, but no one inside the organization is breathing easy yet.
For now, the Braves can only wait. Strider will meet with Dr. Meister in Dallas this week. The next update could define the trajectory of the entire Braves season.
Leave a Comment